Top Markets
Coin of the day
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
주식 순위 #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
주가
$0.20876331
시가총액
$1.38M
변동 (1일)
1.15%
변동 (1년)
-64.84%
국가
FR
거래 IntegraGen SA (ALINT)

카테고리

IntegraGen SA (ALINT)의 매출
Dec 2025 기준 매출 TTM: $5.89M
IntegraGen SA의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $5.89M입니다. 2023년에 회사는 $13.86M의 수익을 올렸으며 이는 2022년의 $14.12M 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
IntegraGen SA의 수익 기록 (2008 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $5.89M -34.91%
2024 $9.05M -34.70%
2023 $13.86M -1.87%
2022 $14.12M 9.68%
2021 $12.88M 17.75%
2020 $10.94M 17.72%
2019 $9.29M 16.30%
2018 $7.99M 2.28%
2017 $7.81M 18.34%
2016 $6.60M 5.01%
2015 $6.28M -15.26%
2014 $7.42M -0.36%
2013 $7.44M 19.02%
2012 $6.25M 3.91%
2011 $6.02M 36.01%
2010 $4.43M 9.71%
2009 $4.03M 28.07%
2008 $3.15M 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$52.05B 883,391.72%
DK
$12.26B 207,933.89%
US
$14.92B 253,164.55%
US
$9.08B 154,074.16%
BE
$6.29B 106,681.86%
NL